Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI
Clinical Radiology, 07/03/2012
Chong YS et al. – A target appearance on the 10 min hepatobiliary phase images is the best predictor for identifying mass–forming intrahepatic cholangiocarcinoma (ICC) at gadoxetic acid–enhanced magnetic resonance imaging (MRI).



